Soft contact lens disinfection solution efficacy: clinical Fusarium isolates vs. ATCC 36031

Emma B H Hume1, Judith Flanagan, Simin Masoudi

  • 1Institute for Eye Research, The School of Optometry and Vision Science, The University of New South Wales, Kensington, New South Wales, Australia. e.hume@ier.org.au

Abstract

Insights

Clinical isolates of Fusarium solani showed greater resistance to multipurpose disinfection solutions (MPDS) than the standard strain. Testing MPDS with clinical isolates is crucial for ensuring effective soft contact lens disinfection.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Soft contact lens wear is associated with microbial keratitis.
  • Multipurpose disinfection solutions (MPDS) are essential for maintaining contact lens hygiene.
  • Fusarium solani is a significant ocular pathogen causing keratitis.

Purpose of the Study:

  • To evaluate the efficacy of five MPDS against clinical isolates of Fusarium solani.
  • To compare the performance of MPDS against clinical isolates versus the standard ATCC 36031 strain.
  • To assess the impact of fungal suspension preparation on disinfection efficacy.

Main Methods:

  • Three commercial and two recalled MPDS were tested.
  • The ISO/CD 14,729 stand-alone test was employed.
  • Ten ocular isolates of F. solani and the ATCC 36031 strain were used.
  • The effect of filtering fungal suspensions was examined.

Main Results:

  • Clinical isolates of F. solani demonstrated significantly higher resistance to MPDS compared to the ATCC 36031 strain.
  • Polyquaternium-based MPDS showed greater efficacy than biguanide-based solutions.
  • Recalled MPDS exhibited lower efficacy than commercially available polyquaternium-based solutions.
  • Filtering fungal suspensions impacted efficacy for one clinical isolate.

Conclusions:

  • Clinical isolates of F. solani are more resistant to disinfection than the standard laboratory strain.
  • Current disinfection testing using only standard strains may not fully represent real-world efficacy.
  • Incorporating clinical isolates into MPDS efficacy testing is recommended for enhanced assurance of disinfection performance.